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Abstract
AMP-activated protein kinase (AMPK) and mammalian Target of Rapamycin (mTOR) are key regulators of cellular energy
balance and of the effects of leptin on food intake. Acute exercise is associated with increased sensitivity to the effects of
leptin on food intake in an IL-6-dependent manner. To determine whether exercise ameliorates the AMPK and mTOR
response to leptin in the hypothalamus in an IL-6-dependent manner, rats performed two 3-h exercise bouts, separated by
one 45-min rest period. Intracerebroventricular IL-6 infusion reduced food intake and pretreatment with AMPK activators
and mTOR inhibitor prevented IL-6-induced anorexia. Activators of AMPK and fasting increased food intake in control rats to
a greater extent than that observed in exercised ones, whereas inhibitor of AMPK had the opposite effect. Furthermore, the
reduction of AMPK and ACC phosphorylation and increase in phosphorylation of proteins involved in mTOR signal
transduction, observed in the hypothalamus after leptin infusion, were more pronounced in both lean and diet-induced
obesity rats after acute exercise. Treatment with leptin reduced food intake in exercised rats that were pretreated with
vehicle, although no increase in responsiveness to leptin-induced anorexia after pretreatment with anti-IL6 antibody, AICAR
or Rapamycin was detected. Thus, the effects of leptin on the AMPK/mTOR pathway, potentiated by acute exercise, may
contribute to appetite suppressive actions in the hypothalamus.
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Introduction
Prolonged exercise of medium to high intensity is known to
profoundly affect energy balance [1–3]. Studies of individuals who
have maintained significant weight loss for .1 year have
demonstrated that dieters who achieve long-term success are
often those who engage in regular and extensive exercise programs
[4]. Although the energy expenditure aspects of such exercise may
contribute to the effects of weight maintenance, it has been
suggested that exercise may also contribute to the energy balance
by altering food intake [5,6]. Rodents submitted to exercise have
increased sensitivity to leptin, conversely animals with diet-induced
obesity and most obese humans are resistant to leptin [5,7,8].
Thus, the mechanism for leptin increased responsiveness in
exercise is of great interest and understanding this mechanism
could lead to new approaches to prevent or treat obesity.
The hypothalamus plays a central role in integrating hormonal
(leptin and insulin) and nutritional signals from the periphery and
modulating food intake, energy expenditure, and peripheral
metabolism [9]. Multiple factors control food intake, including
hormones, fuels and behaviour. AMPK is the downstream
component of a kinase cascade that acts as a sensor of cellular
energy charge, being activated by rising AMP coupled with falling
ATP. Once activated, AMPK phosphorylates acetyl-CoA carbox-
ylase (ACC) and switches on energy-producing pathways at the
expense of energy-depleting processes [10–12]. Another target
molecule for the control of food intake and energy homeostasis is
represented by the phosphoprotein mammalian target of rapamy-
cin, mTOR, in which the PI(3)K/Akt pathway has been suggested
to affect the mTOR phosphorylation state and catalytic activity
[13]. Activated signaling through mTOR phosphorylates the
serine/threonine kinase p70S6K and the translational repressor
eukaryotic initiation factor (eIF) 4E binding protein (4EBP1)
[14,15]. mTOR signaling is inhibited under conditions of low
nutrients, such as glucose and amino acids and low intracellular
ATP levels [16]. While mTOR was presumed to serve as the direct
cellular sensor for ATP levels [17], mounting evidence has
implicated AMPK in the regulation of mTOR activity [15,18–20].
The level of circulating interleukin-6 (IL-6) increases dramat-
ically in response to exercise [21], with IL-6 being produced by
working muscle [22,23] and adipose tissue [24,25] and its
concentration correlates temporally with increases in AMPK in
multiple tissues [26]. In addition, AMPK activity is diminished in
IL-6 deficient mice at rest and the absolute increases in AMPK
activity in these tissues caused by exercise is diminished compared
with control mice [27]. It also appears that centrally-acting IL-6
plays a role in the regulation of appetite, energy expenditure, and
body composition [5,28]. The signaling mechanism of IL-6 in the
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IL-6 to the a subunit of its receptor triggers the recruitment of
gp130, subsequently leading to the activation of the gp130-
associated JAK [29–31]. JAK links cytokine receptor to the
STAT3 and MAP kinase pathway [29,30,32]. In addition to JAK/
STAT and MAP kinase pathways, IL-6 also activates the PI(3)K/
Akt pathway [33].
In this study, we sought to determine whether the improved
response of the AMPK and mTOR pathways to leptin could
contribute to the increased molecular response of leptin in rats
submitted to exercise in an IL-6-dependent manner. We therefore,
examined hypothalamic modulation of AMPK/ACC and mTOR
signaling pathways, induced by IL-6, as well as the role of IL-6 in
those signaling pathways induced by leptin in rats after acute
exercise.
Results
IL-6 decreases hypothalamic AMPK and increases mTOR
signaling
To determine whether IL-6 modulates hypothalamic AMPK/
ACC signaling, we injected IL-6 into the third ventricle of rats and
evaluated food intake and AMPK signaling. IL-6 caused a
significant reduction in food intake (Figure 1a). We next
investigated whether the microinfusion of IL-6 modulates the
hypothalamic ATP concentration. Figure 1b shows that IL-6
(200 ng) changed ATP, ADP and AMP concentrations in the
hypothalamus of rats, whereas, sixty minutes after IL-6 injection,
the ATP content increased by ,88% (Figure 1c) and decreased
AMP:ATP ratio by ,54% in Wistar rats (Figure 1d). Consistent
with the modulation of the AMP:ATP ratio, we observed reduced
hypothalamic AMPK and ACC phosphorylation induced by IL-6
(Figures 1e and f); whilst IL-6 increases p70S6K and 4EBP1
phosphorylation (Figures 1g and h). The aAMPK, ACC, p70S6K
and 4EBP1 protein levels were not different between the groups
(Figures 1e–h, lower panels).
If the effect of IL-6 on food intake is mediated by AMPK
inhibition, AICAR infusion at doses that do not change food
intake, but still increase AMPK and ACC phosphorylation, could
be sufficient to block the effects of IL-6. Thus, to determine
whether the effects of IL-6 on food intake are AMPK-dependent,
we first identified a dose of AICAR that did not alter food intake
(0.5 mM) when administered at the onset of the dark cycle. We
then evaluated the effect of i.c.v. pretreatment with this dose of
AICAR, or its vehicle, on the anorectic response to i.c.v. IL-6
(200 ng) and we observed that the anorectic response to i.c.v. IL-6
was reversed by AICAR at the time points studied (figure 1a).
These findings indicate that inactivation of neuronal AMPK is
necessary for some of the effects of IL-6 on food intake.
Immunohistochemistry with anti-Interleukin-6 Receptor (IL-
6R)-specific antibody showed that IL-6R is expressed in a majority
of neurons in the arcuate nucleus (Figure 1i). Double-staining
confocal microscopy showed the positive immunoreactivity of IL-
6R and AMPK in the hypothalamic arcuate nucleus of rats
60 minutes after i.c.v. saline or IL-6 (200 ng) infusion. The
immunoreactivity of IL-6R and pp70S6K was not detected in the
hypothalamic arcuate nucleus of rats after i.c.v. saline infusion.
However, we observed the positive double-staining of IL-6R and
pp70S6K 60 minutes after i.c.v. IL-6 (200 ng) infusion (Figure 1j).
IL-6 induction of hypothalamic mTOR does not require
changes in PI(3)K signaling
If the effect of IL-6 on food intake is mediated by mTOR
activation, Rapamycin infusion at doses that do not change food
intake, but still decrease p70S6K and 4EBP1 phosphorylations
could be sufficient to block the effects of IL-6. Thus to determine
whether IL-6 modulates hypothalamic mTOR signaling, we
injected IL-6 (200 ng) into the third ventricle of rats and evaluated
food intake and mTOR signaling. IL-6 caused a significant
reduction in food intake (Figure 2a) and induced hypothalamic
p70S6K and 4EBP1 phosphorylation (Figures 2b and c). The
p70S6K and 4EBP1 protein levels were not different between the
groups (Figures 2b and c, lower panels). To determine whether the
effects of IL-6 on food intake are mTOR-dependent, we first
identified a dose of Rapamycin that did not alter food intake
(25 mg) when administered at the onset of the dark cycle. We then
evaluated the effect of i.c.v. pretreatment with this dose of
Rapamycin or its vehicle, on the anorectic response to i.c.v. IL-6
and we observed that IL-6 reduction of food intake was reversed
by Rapamycin.
We next examined whether PI(3)K signaling is required for the
IL-6-dependent reduction of food intake, by IL-6 administration in
LY294002 pretreated (i.c.v.) animals. Pretreatment with
LY294002 at a dose that did not alter food intake (1 nmol) had
no effect on anorectic response to i.c.v. IL-6 (Figure 2d).
Consistent with these data, we observed that a single IL-6 i.c.v.
injection did not change Akt phosphorylation status in the
hypothalamus (Figure 2e). The Akt protein levels were not
different between the groups (Figure 2e, lower panel). These
findings indicates that activation of neuronal mTOR is necessary
for some of the effects of IL-6 on food intake and that these effects
of IL-6 do not require any change in PI(3)K signaling.
We also injected IL-6 (200 ng) into the third ventricle of rats
and evaluated food intake and JAK2/STAT3 signaling. IL-6
caused a significant reduction in food intake (Figure 2f) and
induced hypothalamic JAK2 and STAT3 phosphorylation
(Figures 2g and h). The JAK2 and STAT3 protein levels were
not different between the groups (Figures 2g and h, lower panels).
To determine whether the effects of IL-6 on food intake are also
JAK2/STAT3-dependent, we first identified a dose of AG490 that
did not alter food intake when administered at the onset of the
dark cycle. We then evaluated the effect of i.c.v. pretreatment with
this dose of AG490 or its vehicle, on the anorectic response to i.c.v.
IL-6 and we observed that IL-6 reduction of food intake was
reversed by AG490 (Figure 2f).
Physiological parameters measured in basal conditions
after exercise protocol
The plasma glucose level was lower in the exercised group
compared to the control group (3.660.8 vs 4.660.5 mmol/L;
n=5; p,0.05) and the insulin levels were also lower (88612 vs
193617 pmol/L, n=5; p,0.05). Exercise did not, however,
reduce plasma leptin (2.660.5 vs 2.360.7 ng/ml). Insulinemia and
leptinemia were not altered by third ventricle microinjection of
leptin (data not shown).
Exercise partially reverses the effects of AMPK agonists
and fasting on food intake through modulation of the
AMPK-mTOR signaling pathway in the hypothalamus
To test the role of a single session of exercise on AICAR-
increased food intake, AICAR (2 mM) or its vehicle were
administered (i.c.v.) to control and exercised animals. 12-hour
total food intake was measured after exercise. In exercised rats,
AICAR (2 mM) did not cause any acute change in food intake but,
in the control group, AICAR (2 mM) increased food intake by
32% (Figure 3a), suggesting that AICAR is not effective in
exercised rats. Comparing AICAR-treated groups (control vs.
Exercise and Leptin Action
PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e3856Figure 1. Effects of IL-6 on food intake, hypothalamic AMPK/mTOR activity and ATP content. (a) Effect of i.c.v. administration of IL-6 on
food intake; pretreatment with AICAR blocks IL-6-induced anorexia (n=12–15 animals per group). (b, c, d) Typical chromatographic run (b) depicting
the ATP, ADP, and AMP fractions in control (black line) and in i.c.v. IL-6 treated animals (red line), as mean ATP content and as AMP:ATP ratio (c, d). (e,
f, g, h) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPK
thr172,
threonine-phosphorylated AMPK and total AMPK (e); phospho-ACC
ser79, serine phosphorylated ACC and total ACC (f); phospho-p70S6Kinase
thr389,
threonine phosphorylated p70S6Kinase and total p70S6K (g); phospho-4EBP1
thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (h). Confocal
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total food intake (Figure 3a).
Consistent with food intake, AICAR increased AMPK threo-
nine and ACC serine phosphorylation levels in the hypothalami of
control rats, whilst in exercised animals, AICAR did not change
AMPK/ACC phosphorylation status (Figures 3b and c). Com-
paring AICAR treated groups (control vs. exercise), exercised
animals showed reductions in AMPK threonine and ACC serine
phosphorylation of 52% and 31%, respectively. AICAR reduced
p70S6K and 4EBP1 threonine phosphorylation levels in the
hypothalamus of control and exercised rats. However, comparing
AICAR treated groups (control vs. exercise), exercised animals
showed increases in p70S6K and 4EBP1 threonine phosphoryla-
tion of 230% and 310%, respectively (Figures 3d and e). The
aAMPK, ACC, p70S6K and 4EBP1 protein levels were not
different between the groups (Figures 3b–e, lower panels). Similar
results were observed after intraperitoneal treatment with 2-DG,
another pharmacological activator of AMPK (Figure 3f–j).
To be sure that the experiments represent a physiological
condition we measured food intake in control and exercised
animals after fasting. In the control animals, prolonged fasting
(48 hours) increased ,35% of food intake during 12-hours of
refeeding period compared to control group. However, in the
fasted rats, acute exercise session prevented fasting-induced
hyperphagic response (Figure 3k). Comparing fasting treated
groups (control vs. exercise), exercised animals showed reductions
in AMPK threonine and ACC serine phosphorylation of 65% and
41%, respectively (Figures 3l and m). Comparing fasting groups
(control vs. exercise), exercised animals showed increases in
p70S6K and 4EBP1 threonine phosphorylation of 261% and
240%, respectively (Figures 3n and o). The aAMPK, ACC,
p70S6K and 4EBP1 protein levels were not different between the
groups (Figures 3l–o, lower panels).
Intracerebroventricular a-LA reduces food intake by
modulating AMPK-mTOR hypothalamic phosphorylation
levels to a greater extent in exercised animals
a-LA is an essential cofactor of mitochondrial respiratory
enzymes and exerts potent anti-obesity effects by suppressing
hypothalamic AMPK activity [34]. The effects of a-LA (3 mg)
intracerebroventricular administration, or its vehicle, on food
intake control were studied by measuring the 12-hour total food
intake after an acute exercise bout. In exercised rats, a-LA (3 mg)
reduced food intake by 86% while control group showed a
reduction of 58%. Comparing a-LA treated groups (control vs.
exercise), exercised animals showed a 64% reduction in 12-hour
total food intake (Figure 4a).
To determine the effects of exercise on the AMPK-mTOR
signaling pathway, a-LA was i.c.v. administered and AMPK,
ACC, p70S6K and 4EBP1 phosphorylation levels were assessed in
the hypothalamus of all rats. a-LA reduced AMPK and ACC
phosphorylation levels, in the hypothalami of control and
exercised rats. Comparing a-LA treated groups (control vs.
exercise), in exercised animals a-LA reduced both AMPK
threonine phosphorylation and ACC serine phosphorylation of
39% and 57%, respectively (Figures 4b and c).
a-LA induced p70S6K and 4EBP1 threonine phosphorylation
in the hypothalami of control and exercised rats. Comparing a-LA
treated groups (control vs. exercise), in exercised animals, a-LA
increased p70S6K and 4EBP1 threonine phosphorylation of 19%
and 11%, respectively (Figures 4d and e). a-LA did not change
aAMPK, ACC, p70S6K and 4EBP1 protein expression
(Figures 4b–e, lower panels).
Intracerebroventricular leptin reduces food intake by
modulating AMPK-mTOR hypothalamic phosphorylation
levels to a greater extent in exercised animals
The effects of leptin (10
26 M) i.c.v. administration or its vehicle
on food intake control were studied by measuring the 12-hour
total food intake after an acute exercise bout. In exercised rats,
leptin (10
26 M) reduced food intake by 43%, when compared with
exercised plus vehicle treated group, while the control group
showed a reduction of 25%, when compared with vehicle treated
group. Comparing leptin-treated groups (control vs. exercise),
exercised animals showed a 31% reduction in 12-hour total food
intake (Figure 5a).
To determine the effects of exercise on AMPK-mTOR
signaling pathway, leptin was i.c.v. administered and AMPK,
ACC, p70S6K and 4EBP1 phosphorylation levels were assessed in
the hypothalamus of all rats. Leptin reduced AMPK and ACC
phosphorylation levels in the hypothalami of control and exercised
rats. Comparing leptin-treated groups (control vs. exercise), in
exercised animals, leptin reduced both AMPK threonine phos-
phorylation and ACC serine phosphorylation of 57% and 45%,
respectively (Figures 5b and c). Leptin induced p70S6K and
4EBP1 threonine phosphorylation in the hypothalamus of control
and exercised rats. Comparing leptin treated groups (control vs.
exercise), in exercised animals, leptin increased both p70S6K and
4EBP1 threonine phosphorylation of 30% and 40% respectively
(Figures 5d and e). The aAMPK, ACC, p70S6K and 4EBP1
protein levels were not different between the groups (Figures 5b–e,
lower panels).
Role of IL-6 in anorectic response to leptin
Hypothalamic IL-6 expression was detected in control animals;
however, a 420% increase was observed in the exercised group
(Figure 6a). We tested whether the inhibitory effects of leptin on
food intake depends on IL-6, by i.c.v. infusion of anti–IL-6
antibody into exercised rats. Treatment with leptin (10
26 M)
markedly reduced 12-h food intake in exercised rats pretreated
with vehicle, although pretreatment with anti–IL-6 antibody
blocked exercise-induced leptin responsiveness in a concentration-
dependent manner (Figure 6b).
Both AMPK and ACC phosphorylation levels, reduced by
exercise, were reversed by anti–IL-6 antibody (Figure 6c and d).
We also observed that the increased phosphorylations of p70S6K
and 4EBP1, induced by exercise, were also reversed by anti–IL-6
infusion (Figures 6e and f). The aAMPK, ACC, p70S6K and
4EBP1 protein levels were not different between the groups
(Figures 6c–f, lower panels).
The role of IL-6 on leptin responsiveness in the
hypothalamus of diet-induced obesity (DIO) rats
We next investigated the effect of IL-6 on leptin responsiveness
in the hypothalamus of diet-induced obesity (DIO) rats after acute
exercise. Hypothalamic IL-6 expression was detected in the
microscopy was performed using IL-6 receptor (IL-6R)-specific antibody (green) and DAPI (blue), with 506magnification (i). Co-localization of IL-6R
(green) and AMPK (red) and IL-6R (green) and phospho-p70S6K (red) 60 minutes after i.c.v. saline or IL-6 infusion in the arcuate nuclei of rats, with
2006magnification (j). Data are the means6SEM. *p,0.05, vs. control group; **p,0.01, vs. control group; # p,0.05, vs. other groups.
doi:10.1371/journal.pone.0003856.g001
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PLoS ONE | www.plosone.org 4 December 2008 | Volume 3 | Issue 12 | e3856Figure 2. Effects of IL-6 on food intake and hypothalamic PI(3)K/mTOR and JAK/STAT activity. (a) Pretreatment with Rapamycin blocks
IL-6-induced anorexia (n=10–12 animals per group). (b, c) Representative Western blots of four independent experiments showing hypothalamic
lysates from Wistar rats. Phospho-p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K (b); phospho-4EBP1
thr70, threonine
phosphorylated 4EBP1 and total 4EBP1 (c). (d) Pretreatment with LY294002 had no effect on anorectic response to IL-6 (n=10–12). (e) Representative
western blot of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-Akt
ser473, serine phosphorylated Akt and total
Akt. (f) Pretreatment with AG490 blocks IL-6-induced anorexia (n=10–12 animals per group). (g, h) Representative Western blots of four independent
experiments showing hypothalamic lysates from Wistar rats. Phospho-JAK2, tyrosine phosphorylated JAK2 and total JAK2 (g); phospho-STAT3,
Tyrosine phosphorylated STAT3 and total STAT3 (h). Data are the means6SEM. **p,0.01, vs. control group; # p,0.05, vs. other groups.
doi:10.1371/journal.pone.0003856.g002
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156% increase was observed in the DIO rats after acute exercise
(Figure 7a). The effects of leptin (10
26 M) i.c.v. administration on
energy intake control were studied by measuring the 12-hour total
food intake after an acute exercise bout in DIO rats. Comparing
leptin-treated rats (control vs. DIO), the energy intake was 28%
higher in DIO rats after leptin infusion. However, the i.c.v.
infusion of leptin was able to reduce the energy intake by about
31% in DIO rats after the exercise protocol, compared to DIO
rats at rest (Figure 7b). Interestingly, the i.c.v. pretreatment with
anti-IL-6 antibody (25 ng) blunted the anorexigenic effects of
leptin in exercised DIO rats.
To determine the effects of exercise on the AMPK-mTOR
signaling pathway in the hypothalamus of DIO rats, leptin was
i.c.v. administered and AMPK, ACC, p70S6K and 4EBP1
phosphorylation levels were assessed in the hypothalamus. The
suppressive effects of i.c.v. infusion of leptin on AMPK and ACC
phosphorylation were impaired in the hypothalamus of DIO rats
by about 58 and 54%, respectively, when compared to the control
group (Figure 7c and d). In exercised DIO rats, leptin reduced the
phosphorylation of AMPK by 65% and ACC by 37%, compared
to DIO rats at rest and the i.c.v. pretreatment with anti-IL6
antibody before the exercise protocol, reversed the suppressive
effects of leptin on AMPK/ACC pathway in the hypothalamus of
exercised DIO rats (Figures 7c and d). The AMPK and ACC
protein levels did not differ between the groups (Figures 7c and d,
lower panels).
In addition, p70S6K and 4EBP1 phosphorylation in the
hypothalamus of DIO rats after i.c.v. leptin infusion was reduced
by about 46% and 45%, respectively, when compared to the
control group. In exercised DIO animals, leptin increased the
phosphorylation of p70S6K by 62% and 4EBP1 by 59%,
compared to DIO rats at rest. I.c.v. pretreatment with anti-IL6
antibody before the exercise protocol blocked these effects in the
hypothalamus of exercised DIO rats (Figures 7e and f). The
p70S6K and 4EBP1 protein levels were not different between the
groups (Figures 7e and f, lower panels).
Blocking effects of AICAR and Rapamycin on leptin-
induced anorexia
We tested whether the i.c.v. administration of AICAR or
Rapamycin, 60 minutes before the administration of leptin
(10
26 M), prevents the anorexigenic effects of leptin. Leptin
(10
26 M) treatment markedly reduced 12-h food intake in both
control and exercised groups, although leptin was much more
effective in exercised rats. AICAR (0.5 mM) or Rapamycin
(25 mg), at doses that do not alter ingestion, completely blocked
the suppression of food intake induced by an i.c.v. injection of
leptin (10
26 M) (Figure 8a). The i.c.v. administration of leptin
(10
26 M) to exercised rats pretreated with vehicle reduced AMPK
and ACC phosphorylation in the hypothalamus by 63% and 60%
respectively, compared with the control group. The administration
of AICAR increased AMPK threonine and ACC serine
phosphorylation, although at this dose, AICAR was not sufficient
to induce significant an increase in food intake in exercised
animals (data not shown). Comparing exercised animals, i.c.v.
administration of leptin (10
26 M) to rats pretreated with AICAR
increased both AMPK and ACC phosphorylation levels in the
hypothalamus (Figures 8b and c).
The i.c.v. administration of leptin (10
26 M) to exercised rats
pretreated with vehicle induced p70S6K and 4EBP1 phosphor-
ylation in the hypothalamus of 60% and 70%, respectively,
compared with the control group. Comparing exercised animals,
i.c.v. administration of leptin (10
26 M) to rats pretreated with
AICAR reduced both p70S6K and 4EBP1 phosphorylation levels
in the hypothalamus. Exercised animals pretreated with Rapamy-
cin also reduced hypothalamic p70S6K and 4EBP1 phosphory-
lation (Figures 8d and e). The aAMPK, ACC, p70S6K and
4EBP1 protein levels were not different between the groups
(Figures 8b–e, lower panels).
Discussion
During the last decade, a substantial number of studies have
investigated the role of physical activity in the control of energy
intake in rodents [5,6,35] and in humans [36–38]. However, the
molecular mechanisms by which exercise controls food intake are
still unsolved. Several experimental studies have demonstrated that
neither acute [5,36] nor chronic [6,39] exercise per se change food
intake, on the other hand, accumulating evidence shows that both
acute and chronic exercise potentiate the anorexigenic effects of
leptin in the hypothalamus. Our data indicate that IL-6 signaling
through AMPK and mTOR reduces food intake in a dose-
dependent manner. Leptin, as well as a-LA infusion, reduced food
intake in exercised rats to a greater extent than that observed in
control animals. Conversely, AICAR, 2-DG and fasting increased
food intake in exercised rats to a lower extent than that observed in
control animals. Exercise was associated with the effects of leptin
on the AMPK/mTOR pathway activity in the hypothalamus. In
addition, we investigated the regulatory role of IL-6 in mediating
the increase in leptin responsiveness in the hypothalamus.
Treatment with leptin markedly reduced food intake, AMPK
activity and increased mTOR activity in exercised rats that were
pretreated with vehicle, although no increase in response to leptin-
induced anorexia and modulation of AMPK/mTOR pathway
were detected after i.c.v. pretreatment with anti-IL-6 antibody.
Taken together, these results suggest that IL-6 is a major
component of the effects of exercise on the control of food intake.
Increasing evidence shows that leptin and IL-6 activates AMPK
in the peripheral tissues, such as skeletal muscle and adipose tissue,
increasing fatty acid oxidation and glucose uptake in these tissues
[40–42], however, leptin has an opposing effect in hypothalamic
tissue, reducing neuronal AMPK activity [12,43]. As well as in
response to leptin, in the present study, we demonstrated that IL-6
alone reduced AMPK phosphorylation in the hypothalamus of
rats. We also show that, IL-6 increased ATP levels and decreased
Figure 3. AICAR, 2-DG and fasting effects on 12-h cumulative food intake and AMPK/mTOR signaling, in the hypothalami of control
and exercised rats. (a) AICAR (2 mM) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour
period (n=12–15 animals per group). (b, c, d, e) Representative Western blots of five independent experiments showing hypothalamic lysates from
Wistar rats. (f) 2-DG (500 mg/Kg) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period
(n=12–15 animals per group). (g, h, i, j) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar
rats. (k) Exercise decreases food intake in the fasting state (48 h fasting). Animals were immediately exposed to food for a 12-hour period (n=12–15
animals per group). (l, m, n, o) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats.
Phospho-AMPK
thr172, threonine-phosphorylated AMPK and total AMPK; phospho-ACC
ser79, serine phosphorylated ACC and total ACC; phospho-
p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K; phospho-4EBP1
thr70, threonine phosphorylated 4EBP1 and total 4EBP1.
Data are the means6SEM. * p,0.05, ** p,0.01, vs. control group; # p,0.05, ## p,0.001 vs. AICAR- or 2-DG-stimulated control group.
doi:10.1371/journal.pone.0003856.g003
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PLoS ONE | www.plosone.org 7 December 2008 | Volume 3 | Issue 12 | e3856Figure 4. a-LA effects on 12-h cumulative food intake and AMPK/mTOR signaling, in the hypothalami of control and exercised rats.
(a) a-LA (3 mg) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period (n=8–10 animals per
group). (b, c, d, e) Representative Western blots of four independent experiments showing hypothalamic lysates from Wistar rats. Phospho-
AMPK
thr172, threonine-phosphorylated AMPK and total AMPK (b); phospho-ACC
ser79, serine phosphorylated ACC and total ACC (c); phospho-
p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K (d); phospho-4EBP1
thr70, threonine phosphorylated 4EBP1 and total
4EBP1 (e). Data are the means6SEM. * p,0.05, vs. control group; # p,0.05, vs. exercised non-stimulated group.
doi:10.1371/journal.pone.0003856.g004
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PLoS ONE | www.plosone.org 8 December 2008 | Volume 3 | Issue 12 | e3856Figure 5. Leptin effects on 12-h cumulative food intake and AMPK/mTOR signaling, in the hypothalami of control and exercised
rats. (a) Leptin (10
26 M) was administered in control and exercised rats. Animals were immediately exposed to food for a 12-hour period (n=12–15
animals per group). (b, c, d, e) Representative Western blots of five independent experiments showing hypothalamic lysates from Wistar rats.
Phospho-AMPK
thr172, threonine-phosphorylated AMPK and total AMPK (b); phospho-ACC
ser79, serine phosphorylated ACC and total ACC (c); phospho-
p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K (d); phospho-4EBP1
thr70, threonine phosphorylated 4EBP1 and total
4EBP1 (e). Data are the means6SEM. * p,0.05, ** p,0.01, vs. control group; # p,0.05, ## p,0.01 vs. leptin-stimulated control group.
doi:10.1371/journal.pone.0003856.g005
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PLoS ONE | www.plosone.org 9 December 2008 | Volume 3 | Issue 12 | e3856Figure 6. Blockade of leptin induced inhibition of food intake by anti–IL-6 antibody. Hypothalami from rats were prepared as described in
Research Design and Methods. (a) Tissue extracts from control and exercised rats were immunoblotted with anti–IL-6 antibody. (b) Leptin was injected
intracerebroventricularly in control rats, exercised rats and exercised rats pretreated with anti–IL-6 at the doses indicated, and the animals were
immediately exposed to food for a 12-hour period (n=10–12 animals per group). (c, d, e, f) Representative Western blots of four independent
experiments showing hypothalamic lysates from Wistar rats. Phospho-AMPK
thr172, threonine-phosphorylated AMPK and total AMPK (c); phospho-
ACC
ser79, serine phosphorylated ACC and total ACC (d); phospho-p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K (e);
phospho-4EBP1
thr70, threonine phosphorylated 4EBP1 and total 4EBP1 (f). Data are the means6SEM. *p,0.05, vs. control, **p,0.05, vs. control plus
leptin, #p,0.05, vs. exercise plus leptin.
doi:10.1371/journal.pone.0003856.g006
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PLoS ONE | www.plosone.org 10 December 2008 | Volume 3 | Issue 12 | e3856Figure 7. Leptin effects on 12-h cumulative food intake and AMPK/mTOR signaling in the hypothalami of control, DIO and
exercised DIO rats. (a) Representative Western blots of five independent experiments showing hypothalamic IL-6 expression in DIO Wistar rats at
rest and immediately after acute exercise. (b) Leptin (10
26 M) was administered in control, DIO and exercised DIO rats. Animals were immediately
exposed to food for a 12-hour period (n=12–15 animals per group). (c, d, e and f) Representative Western blots of five independent experiments
showing hypothalamic lysates from Wistar rats. Phospho-AMPK
thr172, threonine-phosphorylated AMPK and total AMPK (c); phospho-ACC
ser79, serine
phosphorylated ACC and total ACC (d); phospho-p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K (e); phospho-4EBP1
thr70,
threonine phosphorylated 4EBP1 and total 4EBP1 (f). Data are the means6SEM. * p,0.05, vs. control group, # p,0.05, vs. DIO group.
doi:10.1371/journal.pone.0003856.g007
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PLoS ONE | www.plosone.org 12 December 2008 | Volume 3 | Issue 12 | e3856the AMP/ATP ratio in the hypothalamus (figures 1b–d), but the
mechanisms by which IL-6 modulates the ATP levels require
further investigations.
A number of recent studies have shown that AMPK plays a key
roleinregulatingboth energyintakeand expenditure [12,34,44,45].
In peripheral tissues, such as skeletal muscle, activation of AMPK
switches on energy producing pathways and switches off energy
consuming pathways. In the hypothalamus, activation of AMPK
leads to increased feeding, thereby increasing energy intake.
Conversely, inhibition of AMPK in the hypothalamus reduces food
intake. These dual functions of AMPK suggest that it may act to
coordinate energy expenditure with energy intake. There is already
some evidence that this may be the case in one situation. More
recently, Gao and colleagues [10] demonstrated that the hypotha-
lamic ACC activation makes an important contribution to the
anorexigenic effects of leptin that are mediated by AMPK. The aim
of this study was to investigate whether IL-6 could affect AMPK
activity in the hypothalamus, thereby providing a potential
mechanism for the coordination of energy expenditure and energy
intake during, or following exercise. Beyond STAT3 activation, we
detected changes in the hypothalamic AMPK activity in rats after
i.c.v. infusion of IL-6; we show that, IL-6 markedly decreased
phospho-AMPK abundance (an index of activity) in the hypothal-
amus. In accordance with the reduction in AMPK
thr172 phosphor-
ylation, we observed that, after IL-6 administration, hypothalamic
AMP:ATP ratio was decreased.
Wallenius et al [28] elegantly showed that long-term peripheral
IL-6 treatment to Il6
2/2 mice caused a decrease in body weight.
In addition to increasing energy expenditure, IL-6 may prevent
obesity by inhibiting feeding as obese IL-6
2/2 mice had increased
absolute food intake. However, central IL-6 treatment at the same
dose that we used does not influence food intake in mice. In
concordance with our results another study of the same group
showed a reduced daily food intake over a two-week ICV
treatment period with IL-6 in rats indicating a different pattern of
response between rats and mice [46].
The mTOR, an evolutionary conserved serine-threonine kinase,
central to integrating similar signals to control food intake, has
now emerged as a detector of hormonal and nutritional signals in
the hypothalamus [13,15]. In this study, we investigated whether
IL-6 activates mTOR. IL-6 increased mTOR activity; moreover
inhibition of central mTOR reversed the anorectic effect of IL-6.
In addition, the anorexigenic effect of IL-6 was absent in AICAR-
and Rapamycin-pretreated rats, however, pretreatment with
LY294002 - a PI(3)K inhibitor - had no effect on IL-6 induced
anorexia, indicating that, in the hypothalamus, the effect of IL-6 is
independent of the PI(3)K pathway. Signaling through gp130
commonly results in activation of PI(3)K, and IL-6 can activate
PI(3)K [47] and its downstream target Akt [48–51], but it should
be noted that this effect has not been observed in all studies [52],
suggesting a tissue-dependent effect.
Next, we investigated whether the increased sensitivity of the
leptin action on food intake induced by exercise, could be due to
the modulation of AMPK activity. As previously shown [43],
exercise, per se, does not alter AMPK activity in the hypothal-
amus; however, we observed that the normal inhibition of AMPK
phosphorylation and activity in the hypothalamus, induced by
leptin administration, was improved in both lean and diet-induced
obesity rats after acute protocol of exercise.
In addition, we did not observe any normal stimulation of
AMPK activity by AICAR in the hypothalamus of exercised rats,
indicating that AMPK pathway is disrupted. This observation
agrees with data from aging studies in which acute stimulation
with AICAR was blunted in skeletal muscle of old rats [53].
Furthermore, fasting and the use of another activator of AMPK (2-
DG) in exercising rats resulted in a lower activation of AMPK
when compared to the control animals. In contrast, the
pharmacological inhibition of AMPK by a-LA results in a greater
inhibition of AMPK activity, compared to control animals.
The mechanism by which exercise inhibits AMPK-induced food
intake in the hypothalamus is not clear. Several lines of evidence
point to a possible link between inhibited AMPK-induced food
intake in the hypothalamus and IL-6 signaling through the
AMPK/mTOR pathway. Firstly, we found that the leptin-
inhibited food intake enhanced by exercise was blunted by anti-
IL-6 antibody. Secondly, exercise induced increased response of
leptin-inhibited AMPK signaling was reverted by AICAR. Finally,
exercise induced increased responsiveness of leptin stimulated
mTOR signaling was reverted by rapamycin.
Our data are in accordance with earlier studies demonstrating
that IL-6 treatment enhances energy expenditure in both rodents
and humans [28,54–56]. In exercising rats, hypothalamic leptin and
insulin responsiveness are increased in an IL-6-dependent manner
[5,6]. It has been previously shown that IL-6 treatment stimulates
energy expenditure at the level of the brain in rodents [28,55,57],
and itmight be assumed that endogenousIL-6 alsoactson the brain
during exercise. The IL-6 exerting this effect during exercise could
be produced by the brain itself, which has been shown to have
increased IL-6 production during exercise [58]. Alternatively, the
large quantities of endocrine IL-6 produced from working skeletal
muscle [58] might reach appropriate sites in the brain [21,59,60].
Interestingly, we did not observe any difference in food intake
over a 12-h period, although the levels of hypothalamic IL-6
dramatically increased after exercise. At first glance, these data
appear to be contradictory. However, a large decrease in insulin
level was observed after exercise, and we have previously shown a
synergic effectofIL-6ontheinsulin andleptinsignaling pathway,in
the rat hypothalamus [5]. Since we did not observe modifications in
thephosphorylationofJAK2andthe downstreamtargetsofmTOR
after exercise, these data suggest that the cross-talk between insulin,
IL-6 and leptin have an essential role in controlling food intake after
exercise. In this case, it is possible that increases in IL-6 levels were
counterbalanced by the reduction in insulin levels.
However, the present study has certain limitations. Exercise per
se did not evoke any meaningful effect in terms of food intake;
rather, it seemed to enhance the anorectic effect of exogenous
leptin. Thus, the data presented herein may suggest but do not
establish the mechanism by which long term exercise decreases
leptin levels; whilst increases the response to leptin, contributing to
its food-suppressive actions. Furthermore, settings of activation of
AMPK or inactivation of mTOR were selected to induce changes
in target protein phosphorylation, but not food intake. Such
dissociation does not preclude a pharmacological rather than
physiological effect of our data.
Figure 8. Blocking effects of AICAR and Rapamycin on leptin-induced anorexia. (a) Effect of i.c.v. administration of leptin on exercised rats;
pretreatment with AICAR or Rapamycin (n=8–10 animals per group). (b, c, d, e) Representative Western blots of five independent experiments
showing hypothalamic lysates from Wistar rats. Phospho-AMPK
thr172, threonine-phosphorylated AMPK and total AMPK (b); phospho-ACC
ser79, serine
phosphorylated ACC and total ACC (c); phospho-p70S6Kinase
thr389, threonine phosphorylated p70S6Kinase and total p70S6K (d); phospho-4EBP1
thr70,
threonine phosphorylated 4EBP1 and total 4EBP1 (e). Data are the means6SEM. *p,0.05, vs. other groups.
doi:10.1371/journal.pone.0003856.g008
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through modulation of the AMPK-mediated pathway by exercise,
could be pathophysiologically important in the prevention of
obesity. Recent studies have shown that modulation of leptin
signaling through the AMPK pathway could be involved in the
development of obesity [61]. Taken together, these data indicate
that the anti-obesity actions, induced by leptin, could be increased
due to the more pronounced inhibition of the AMPK pathway
observed after leptin infusion in the hypothalamus of both lean
and diet-induced obesity rats after acute exercise. If the
mechanism used by IL-6 to reduce food intake is AMPK-
dependent, as our results suggest, the defective activation of
AMPK in the hypothalamic neurons induced by exercise may
increase the ability of leptin to reduce food intake.
In conclusion, exercise improved the AMPK and mTOR
responses to leptin administration and contributed to appetite-
suppressive actions. This increased dynamic responsiveness of the
AMPK/mTOR pathway to leptin could provide information
regarding the molecular mechanism underlying the biological
sensitivity to leptin in exercise. Furthermore, these findings provide
support to the hypothesis that AMPK and mTOR interact in the
hypothalamus to control feeding in exercised rats, in an IL-6-
dependent manner.
Methods
Antibodies and Chemicals
Reagents for SDS-polyacrylamide gel electrophoresis and
immunoblotting were from Bio-Rad (Richmond, CA, USA).
Tris[hydroxymethyl]amino-methane (Tris), aprotinin, ATP, di-
thiothreitol, phenylmethylsulfonyl fluoride, Triton X-100, Tween
20, glycerol, and bovine serum albumin (fraction V) were from
Sigma Aldrich (St. Louis, MO, USA). Protein A-Sepharose 6 MB
and Nitrocellulose paper (Hybond ECL, 0.45 mm) from Amer-
sham Pharmacia Biotech United Kingdom Ltd. (Buckingham-
shire, United Kingdom). Ketamin was from Parke-Davis (Sa ˜o
Paulo, SP, Brazil) and diazepam and thiopethal were from
Crista ´lia (Itapira, SP, Brazil). Anti-phospho-[Ser
79] ACC (rabbit
polyclonal, #07-184) and anti-phospho- [Tyr
1007/1008] JAK2
(rabbit polyclonal, AB3805) antibodies were from Upstate
Biotechnology (Charlottesville, VA, USA). Anti-ACC (goat
polyclonal, sc-26816), anti-JAK2 (rabbit polyclonal, sc 278), anti-
STAT3 (rabbit polyclonal, sc 483) and anti-IL-6 (rabbit polyclon-
al, sc-7920) antibodies were from Santa Cruz Biotechnology, Inc.
Anti-phospho-[Thr
172] AMPKa (rabbit polyclonal, #2531), anti-
AMPKa (rabbit polyclonal, #2532), anti-phospho- [tyr705]
STAT3 (rabbit polyclonal, #9135), anti-phospho- [Thr389]
p70S6K (rabbit polyclonal, #9205), anti-p70S6K (rabbit poly-
clonal, #9202), anti-phospho- [Thr70]4EBP1 (rabbit polyclonal,
#9455), anti-4EBP1 (rabbit polyclonal, #9452), anti-phospho-
[Ser 473]Akt (rabbit polyclonal, #9271), and anti-Akt (rabbit
polyclonal, #9272) were from Cell Signalling Technology
(Beverly, MA, USA). Leptin, LY294002, and Interleukin-6 were
from Calbiochem (San Diego, CA, USA); 5-Aminoimidazole-4-
carboxamide 1-b-D-ribofuranoside (AICAR), 2-Deoxy-D-glucose
and a-lipoic acid were from Sigma Chemical Co. (St. Louis, MO).
Rapamycin was from LC Laboratories (Woburn, MA, USA).
Routine reagents were purchased from Sigma Chemical Co. (St.
Louis, MO) unless otherwise specified.
Serum insulin and leptin quantification
Plasma was separated by centrifugation (1100 g) for 15 minutes
at 4uC and stored at 280uC until assayed. RIA was employed to
measure serum insulin, according to a previous description [62].
Leptin concentrations were determined using a commercially
available Enzyme Linked Immuno Sorbent Assay (ELISA) kit
(Crystal Chem Inc, Chicago, IL).
Experimental Animals
Male Wistar rats (8 weeks old/250–300 g) obtained from the
University of Campinas Animal Breeding Center were used in the
experiments.The investigation was approved by the ethics committee
and followed the University guidelines for the use of animals in
experimental studies and conforms to the Guide for the Care and Use of
Laboratory Animals, published by the US National Institutes of Health
(NIH publication no. 85-23 revised 1996). The animals were
maintained on 12h:12h artificial light–dark cycles and housed in
individual cages.
Diet induced obesity (DIO)
Male 4-wk-old Wistar rats from the University of Campinas
Breeding Center were randomly divided into two groups, control,
fed standard rodent chow (3948 kcal.Kg
21) and DIO, fed a fat-
rich chow (5358 kcal.Kg
21) ad libitum for 3 months and then
submitted to the different experimental protocols. This diet
composition has been previously used [63].
Intracerebroventricular (i.c.v.) cannulation
The animals were stereotaxically instrumented under intraper-
itoneal injection of a mix of ketamin (10 mg) and diazepam
(0.07 mg) (0.2 ml/100 g body weight) with a chronic 26-gauge
stainless steel indwelling guide cannula, aseptically placed into the
third ventricle (0.5 mm posterior and 8.5 mm ventral to bregma),
as previously described [64]. After a 1-wk recovery period,
cannula placement was confirmed by a positive drinking response
after administration of Angiotensin II (40 ng/2 mL); animals that
did not drink 5 mL of water within 15 minutes after treatment
were not included in the experiment.
Exercise Protocol
Rats were acclimated to swimming for 2 days (10 min per day).
On the day of the experiment, animals swam in groups of four, in
plastic barrels of 45 cm in diameter, filled to a depth of 50 cm.
Water temperature was maintained at 34–35uC. They performed
two 3-h exercise bouts, separated by one 45-min rest period, as
previously described [65]. After the last exercise bout, some rats
were injected into the cannula and food intake was determined
over the next 4 and/or 12 h; the other rats were injected into the
cannula and then anesthetized with intraperitoneal injection of
sodium thiopethal (5 mg/100 g body weight) and hypothalamus
was removed.
Treatments
For acute treatments, rats were deprived of food for 6 h with
free access to water and i.p. injected (200 ml bolus injection) with
either vehicle or 2-DG (500 mg/kg) or i.c.v. injected (3 ml bolus
injection) with either vehicle, IL-6 (100 ng or 200 ng), AICAR (0.5
or 2.0 mM), Rapamycin (25 mg), a-LA (3 mg), leptin (10
26 M),
LY294002 (50 mM) or anti-IL-6 antibody. Similar studies were
carried out in rats that were initially pre-treated with i.c.v.
microinjection of vehicle, AICAR, Rapamycin, anti-IL-6 antibody
or LY294002, and after 60 min with i.c.v. microinjection of IL-6
or leptin. Thereafter, standard chow was given and food intake
was determined by measuring the difference between the weight of
chow given and the weight of chow at the end of 4 and/or 12-h
periods. All acute treatments were performed at 5:00 and 6:00
p.m.
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After exercise and i.c.v. treatments, rats were anaesthetized with
intraperitoneal injection of a mix of ketamin (10 mg) and diazepam
(0.07 mg) (0.2 ml/100 g body weight), and used as soon as anesthesia
was assured by the loss of pedal and corneal reflexes. The rats were
killed, and hypothalamus was quickly removed, minced coarsely and
homogenized immediately in a freshly prepared ice-cold buffer (1%
Triton X-100, 100 mmol/l Tris pH 7.4, 100 mmol/l sodium
pyrophosphate, 100 mmol/l sodium fluoride, 10 mmol/l EDTA,
10 mmol/l sodium vanadate, 2 mmol/l phenyl methylsulphonyl
fluoride and 0.1 mg aprotinin) suitable for preserving phosphoryla-
tion states of enzymes and Western blot was performed, as previously
described [66]. Insoluble material was removed by centrifugation
(50 000 g) for 25 minutes at 4uC. Total extracts of hypothalamus
were prepared and 0.25 mg total proteins were separed by SDS-
PAGE. After SDS-PAGE (15% resolving gels for phospho-4EBP1
and 4EBP1; 12% resolving gels for phospho-AMPK, AMPKa2;
phospho-p70S6K, p70S6K, phospho-Akt, Akt, phospho-STAT3 and
STAT3; 8% resolving gels for phosphor-JAK2 and JAK2; 6.5%
resolving gels for ACC and phospho-ACC),proteins weretransferred
from gel to nitrocellulose membrane. Membranes were blocked in
5% nonfat dried milk in PBST (139 mM NaCl, 2.7 mM KH2PO4,
9.9 mM Na2HPO4, and 0.1% Tween 20) for 2 hours and then
incubated overnight with specific antibodies. After incubation with
the relative second antibody, immune complexes were detected using
the ECL method. Results were visualized by autoradiography using
preflashed Kodak XAR film (Eastman Kodak, Rochester, N.Y.,
USA) with Cronex Lightning Plus intensifying screens at 280uCf o r
12–48 h. (Mass., USA). Band intensities were quantified by optical
densitometry of developed autoradiographs (Scion Image software -
Scion Corporation,F r e d e r i c k ,M d . ,U S A ) .
Confocal microscopy
Paraformaldehyde-fixed hypothalami were sectioned (5 mm).
The sections were obtained from hypothalamus of six rats per
group in the same localization (antero-posterior=21.78 from
bregma) and used in regular single- or double-immunofluores-
cence staining using DAPI, anti-IL6 receptor (IL6R), anti-AMPK,
anti-phospho-p70S6K (1:200; Santa Cruz Biotechnology), anti-
bodies, according to a previously described protocol [67]. Analysis
and photodocumentation of results were performed using a LSM
510 laser confocal microscope (Zeiss, Jena, Germany). The
anatomical correlations were made according to the landmarks
given in a stereotaxic atlas [68].
Chromatography
After exercise, i.c.v. infusion of IL-6 or vehicle, rats were
anaesthetized, and used as soon as anesthesia was assured by the
loss of pedal and corneal reflexes. The animals were killed and,
within 40 seconds, the cranium was opened, the brain was
removed and the hypothalamus was quickly dissected and frozen
in liquid N2 for chromatographic analyses.
Chromatographic analyses were carried out on a Waters Alliance
equipment series 2695 (Milford, MA, USA) equipped with a
quaternary pump, an autosampler, a degasser, and a Waters 2475
fluorescence detector model. The fluorescence of derivatized
compounds (ATP, ADP, AMP, and ADO) was monitored with
excitation and emission wavelengths set at 280 and 420 nm,
respectively. Chromatographic separations of the compounds were
achieved at room temperature, using a reversed-phase Cosmosil
5C18-MS column (15064.6 mm i.d.; 5 mm particle size) with a
Cosmosil guard column (5C18-MS 1064.6 mm) purchased from
Phenomenex (Torrance, CA, USA). The mobile phase composition
was 50 mmol/L KH2PO4, 25 mmol/L citric acid (pH 4.5), and
methanol (90:10, v/v), which was prepared immediately before use
and filtered through a 0.45 mm filter (Millipore, Milford, MA,
USA). The column was equilibrated and eluted under isocratic
conditions using a flow rate of 1.0 ml/min. The chromatographic
run time for each analysis was 20 min. Aliquots of 25 ml were
injected into the HPLC system. System control, data acquisition,
and processing were performed with a PC-Pentium IV Processor
personal computer from Dell, operated with Microsoft Windows
XP version 2003 and Waters Empower 2002 chromatography
software. A validation chromatographic run included a set of
calibration samples assayed in duplicate and quality control samples
at four levels in triplicate. The standard calibration curves for
known amounts of ATP, ranging from 0.025 to 10.0 mmol/L, were
linear (R.0.999) and could be described by the linear regression
equation: y=0.4992*x20.0463 (n=4, P,0.0001, r=0.9997), in
which y is the ATP concentration in micromoles and x is the
chromatogram peak area.
Statistical Analysis
All numeric results are expressed as the means6SEM of the
indicated number of experiments. The results of blots are presented
as direct comparisons of bands or spots in autoradiographs and
quantified by optical densitometry (Scion Image). Statistical analysis
was performed by employing the ANOVA test with Bonferroni post
test. Significance was established at the p,0.05 level.
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